Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Novel clinical trials (CTs) for neurological conditions (n = 69)

From: Is belief larger than fact: expectations, optimism and reality for translational stem cell research

Clinical trial subject

No. of CTs

Country

Amyotrophic lateral sclerosis

7

China, Israel, Spain, USA

Cerebral palsy

3

Mexico, South Korea, USA

Cerebral palsy using MSCs

3

China, India

Diabetic neuropathy

3

Germany, Mexico, USA

Ischemic Stroke

18

Brazil, Canada, France, India, Malaysia, Russia, Spain, Taiwan, UK, USA, Russia

Multiple sclerosis

12

Canada, Israel, Spain, UK, USA

Neuronal ceroid lipfuscinosis

2

USA

Parkinson's Disease

2

India

Pelizaeus-Merzbacher Disease

1

USA

Spinal cord injury (non-hESC)

5

Egypt, India, USA

Spinal cord injury (hESC)

1

USA

Traumatic brain injury

3

Canada, India, USA

Other

10

Brazil, China, The Netherlands, South Korea, Thailand, USA

  1. hESCs = human embryonic stem cells; MSCs = mesenchymal stem cells.